Academic Content and Language Evaluation of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (4826)
All Articles published online
|
Publishing Process of This Article
|
Aug 14, 2013 (publication date) through Apr 23, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Matsumura H, Nirei K, Nakamura H, Higuchi T, Arakawa Y, Ogawa M, Tanaka N, Moriyama M. Histopathology of type C liver disease for determining hepatocellular carcinoma risk factors. World J Gastroenterol 2013; 19(30): 4887-4896 [PMID: 23946593 DOI: 10.3748/wjg.v19.i30.4887] |
|---|---|
| URL: | https://www.wjgnet.com/1948-5182/full/v19/i30/4887.htm |
| Number | Citing Articles |
| 1 |
Akitoshi Douhara, Tadashi Namisaki, Kei Moriya, Mitsuteru Kitade, Kosuke Kaji, Hideto Kawaratani, Kosuke Takeda, Yasushi Okura, Hiroaki Takaya, Ryuichi Noguchi, Norihisa Nishimura, Kenichiro Seki, Shinya Sato, Yasuhiko Sawada, Junichi Yamao, Akira Mitoro, Masakazu Uejima, Tsuyoshi Mashitani, Naotaka Shimozato, Soichiro Saikawa, Keisuke Nakanishi, Masanori Furukawa, Takuya Kubo, Hitoshi Yoshiji. Predisposing factors for hepatocellular carcinoma recurrence following initial remission after transcatheter arterial chemoembolization. Oncology Letters 2017; 14(3): 3028 doi: 10.3892/ol.2017.6489
|
| 2 |
Masahiro Ogawa, Ryota Masuzaki, Tatsuo Kanda, Hiroshi Matsumura, Hitomi Nakamura, Motomi Yamazaki, Toshikatu Shibata, Hirofumi Kogure, Mitsuhiko Moriyama. Involvement of proliferation of atypical hepatocytes and CDT 1 in the liver cancer of rats administered the diethylnitrosamine. Journal of Clinical Biochemistry and Nutrition 2023; 73(2): 138 doi: 10.3164/jcbn.13-16
|
| 3 |
Mitsuhiko Moriyama. Investigation of Hepatocarcinogenesis Mechanisms. Journal of Nihon University Medical Association 2022; 81(5): 309 doi: 10.4264/numa.81.5_309
|
| 4 |
Shunichi Matsuoka, Hirotoshi Fujikawa, Hiromasa Hasegawa, Takanaga Ochiai, Yukinobu Watanabe, Mitsuhiko Moriyama. Onset of Tuberculosis from a Pulmonary Latent Tuberculosis Infection during Antiviral Triple Therapy for Chronic Hepatitis C. Internal Medicine 2016; 55(15): 2011 doi: 10.2169/internalmedicine.55.6448
|
| 5 |
Francesca Romana Ponziani, Francesca Mangiola, Cecilia Binda, Maria Assunta Zocco, Massimo Siciliano, Antonio Grieco, Gian Lodovico Rapaccini, Maurizio Pompili, Antonio Gasbarrini. Future of liver disease in the era of direct acting antivirals for the treatment of hepatitis C. World Journal of Hepatology 2017; 9(7): 352-367 doi: 10.4254/wjh.v9.i7.352
|
| 6 |
An-Na Bae, Jongwan Kim, Jong-Ho Park, Jae-Ho Lee, Euncheol Choi. Comprehensive Analysis of NKX3.2 in Liver Hepatocellular Carcinoma by Bigdata. Medicina 2023; 59(10): 1782 doi: 10.3390/medicina59101782
|
| 7 |
Ian Lockhart, Malcolm Guan Hin Yeo, Behzad Hajarizadeh, Gregory J. Dore, Mark Danta. Hepatocellular Carcinoma Incidence After Hepatitis C Cure Among Patients With Advanced Fibrosis or Cirrhosis: A Systematic Review and Meta-Analysis. SSRN Electronic Journal 2021; doi: 10.2139/ssrn.3950271
|
| 8 |
Ian Lockart, Malcolm G. H. Yeo, Behzad Hajarizadeh, Gregory J. Dore, Mark Danta. HCC incidence after hepatitis C cure among patients with advanced fibrosis or cirrhosis: A meta‐analysis. Hepatology 2022; 76(1): 139 doi: 10.1002/hep.32341
|
| 9 |
Masahiro Ogawa, Mitsuhiko Moriyama, Yutaka Midorikawa, Hitomi Nakamura, Toshikatu Shibata, Kazumichi Kuroda, Hisashi Nakayama, Kazunori Kanemaru, Toshio Miki, Masahiko Sugitani, Tadatoshi Takayama. The significance of CDT1 expression in non-cancerous and cancerous liver in cases with hepatocellular carcinoma. Journal of Clinical Biochemistry and Nutrition 2023; 73(3): 234 doi: 10.3164/jcbn.23-43
|
| 10 |
Tarek K. Motawi, Olfat G. Shaker, Shohda A. El-Maraghy, Mahmoud A. Senousy, Anand S Mehta. Serum MicroRNAs as Potential Biomarkers for Early Diagnosis of Hepatitis C Virus-Related Hepatocellular Carcinoma in Egyptian Patients. PLOS ONE 2015; 10(9): e0137706 doi: 10.1371/journal.pone.0137706
|
| 11 |
Masahiro Ogawa, Mitsuhiko Moriyama, Hitomi Nakamura, Toshikatu Shibata, Kazumichi Kuroda, Masahiko Sugitani. Clinical significance of <i>CDT1</i> mRNA expression in chronic hepatitis C or liver cirrhosis. Journal of Clinical Biochemistry and Nutrition 2024; 74(2): 169 doi: 10.3164/jcbn.23-54
|
| 12 |
Mitsuhiko Moriyama, Tatsuo Kanda, Yutaka Midorikawa, Hiroshi Matsumura, Ryota Masuzaki, Hitomi Nakamura, Masahiro Ogawa, Shunichi Matsuoka, Toshikatu Shibata, Motomi Yamazaki, Kazumichi Kuroda, Hisashi Nakayama, Tokio Higaki, Kazunori Kanemaru, Toshio Miki, Masahiko Sugitani, Tadatoshi Takayama. The proliferation of atypical hepatocytes and CDT1 expression in noncancerous tissue are associated with the postoperative recurrence of hepatocellular carcinoma. Scientific Reports 2022; 12(1) doi: 10.1038/s41598-022-25201-6
|